Allurion Technologies stock analysis
Want to see ALUR full AI Analyst Report?
Allurion Technologies (ALUR) Stock Price & Analysis
ALUR Stock Chart & Stats
- Day’s Range
- $0.01 - $0.02
- 52-Week Range
- $0.01 - $31.04
- Previous Close
- $0.02
- Volume
- N/A
- Average Volume (3M)
- 2,117
- Market Cap
- $2,101
- Enterprise Value
- $33.40M
- Total Cash (Recent Filing)
- $5.06M
- Total Debt (Recent Filing)
- $29.45M
- Price to Earnings (P/E)
- 0.0
- Beta
- 4.07
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Non-surgical Weight-loss Platform
Allurion’s swallowable, temporary balloon addresses weight management through a less invasive delivery model than procedures requiring endoscopy or surgery. Its broader offering also includes digital tools and remote monitoring, creating an integrated program that may support provider adoption and patient engagement.
Solid Gross Margin Base
A gross margin of approximately 53% indicates that the company retains meaningful contribution after direct costs of its offering. If treatment volumes recover, this margin base could provide operating leverage because additional revenue may contribute toward reducing the currently heavy fixed-cost burden.
Debt Has Declined From Prior Levels
Debt trending down from 2022 levels is a constructive capital-management development and could reduce obligations over time if maintained. Lower debt would improve financial flexibility, although the company remains highly leveraged relative to its asset base and still needs to repair its overall capital position.
Bears Say
Persistent Revenue Contraction
Revenue has contracted sharply across multiple reporting periods, falling from $64.2 million in 2022 to $12.6 million on a TTM basis. This sustained decline indicates weakened treatment volume or commercial traction, reducing scale and making it harder for the business to absorb operating costs.
Deep Losses And Ongoing Cash Burn
Large net losses combined with operating and free cash flow of approximately negative $22.7 million show that the business is not funding operations internally. Continued cash consumption can pressure liquidity, constrain investment in growth, and increase dependence on external financing if performance does not improve.
Weak And Highly Strained Capital Position
Negative equity across every reported period and debt exceeding the asset base point to a structurally weak balance sheet. This limits financial flexibility and raises recapitalization or dilution risk, while leaving fewer resources available to withstand continued losses or fund expansion.
Allurion Technologies News
ALUR FAQ
What was Allurion Technologies’s price range in the past 12 months?
What is Allurion Technologies’s market cap?
When is Allurion Technologies’s upcoming earnings report date?
How were Allurion Technologies’s earnings last quarter?
Is Allurion Technologies overvalued?
Does Allurion Technologies pay dividends?
What is Allurion Technologies’s EPS estimate?
How many shares outstanding does Allurion Technologies have?
What happened to Allurion Technologies’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Allurion Technologies?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Allurion Technologies
Allurion Technologies Inc. is dedicated to combating obesity by offering a comprehensive weight management ecosystem designed for individuals with excess weight. At the core of its solution is the Allurion Program, featuring the innovative Allurion Balloon – a novel, non-surgical, swallowable intragastric device engineered to promote significant weight loss. This program is further enhanced by the Allurion Virtual Care Suite, which provides sophisticated AI-powered remote patient monitoring, a specialized behavior modification curriculum, encrypted messaging capabilities, and virtual telehealth consultations. The firm's main operational base is located in Natick, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Shantanu K. Gaur
- Employees
- 40
- Website
- www.allurion.com
- Address
- 11 Huron Drive, Natick, MA, 01760, US
Allurion Technologies (ALUR) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 4 | 3 | 15 |
| Technical Analysis | 3 | 3 | 4 |
| Moving Averages | 1 | 0 | 11 |












